Replies to post #69798 on Regen BioPharma Inc (RGBP)

[Madguppy]

Agree. I have only stuck around the last 2 months was because of a buy out. With the different shares here, we just don't know how that is gonna play out.

[SeniorGolfer]

Nice thanks for your input sounds logical

[Skiluc]

You must have missed the 20 months that Koos was not CEO. 20/20? Common now. There was an interim CEO that literally didnt lift a finger and let EVERYTHING lapse. Filings. Patents. Applications. Everything. Not Dr Koos. Important Fact.

Koos was just reinstated and is correcting the ship. Big time! As fast as humanly possible. Think he brought any “friends” with him?

I doo.

See the zero-dilutive funding.

[Fdc4]

You forgot the website update too. Why waste time and money updating it, if not to attract new buyers, potential deals, etc

[SidVicious]

David Koos is in his 70s? LOL! This wasn't difficult to find.

From SEC 8-K published in March

Five Year Employment History:



David R. Koos, 62 has served as Chairman of the Board of Directors, Chief Executive Officer, President, Secretary and Treasurer of SYBLEU INC., a biotechnology company, from June 12, 2020 to the present. David R. Koos served as Chief Financial Officer of SYBLEU INC. from June 12, 2020 to July 21, 2020. On March 23, 2021 David R. Koos assumed the position of sole officer and director of Zander Therapeutics, Inc., a biotechnology company.

https://sec.report/Document/0001607062-21-000060/rgbp032421form8k.htm#:~:text=Year%20Employment%20History:-,David%20R.,Financial%20Officer%20of%20SYBLEU%20INC.